In a significant move within the consumer health industry, Procter & Gamble (P&G) has announced its acquisition of Thorne, a prominent supplements maker, for $3.8 billion. The deal, confirmed by P&G CEO Shailesh Jejurikar, underscores the company’s commitment to expanding its health and wellness portfolio.
The acquisition, revealed on August 4, 2026, comes at a time when P&G is navigating a complex market landscape. Despite forecasting slower annual sales growth, the company’s beauty and wellness division has shown robust performance, driven by consumer demand for discretionary self-care products.
Strategic Implications of the P&G-Thorne Deal
The acquisition of Thorne is a strategic play for P&G to enhance its presence in the rapidly growing health supplements market. Thorne, previously owned by L Catterton, has been valued at up to $4 billion, according to reports from the Financial Times. The company’s innovative approach to supplements aligns well with P&G’s vision for its health business.
Jejurikar emphasized that the acquisition price is justified by Thorne’s impressive growth rates. ‘The price is a good price for the growth rates they have. It’s kind of in line with the industry benchmarks we’ve seen,’ he stated in an interview with CNBC. This acquisition positions P&G to compete more effectively with other major players in the consumer health sector, such as Haleon and Unilever, who had also expressed interest in acquiring Thorne.
The Market Response and Future Outlook
The announcement of the P&G-Thorne acquisition has garnered attention from industry analysts and investors alike. While P&G and Thorne have not provided additional details, the deal is seen as a positive step towards strengthening P&G’s health division. The acquisition is expected to drive innovation and expand P&G’s product offerings in the wellness space.
Despite the optimistic outlook, P&G’s recent forecast of slower annual sales growth highlights the challenges the company faces in maintaining momentum across all its divisions. The strong performance of the beauty and wellness sector, however, provides a silver lining. This acquisition could further bolster this division, ensuring sustained growth in a competitive market.
As the consumer health industry continues to evolve, P&G’s acquisition of Thorne marks a pivotal moment. The deal not only reflects P&G’s strategic vision but also underscores the growing importance of health and wellness in the consumer market. With this acquisition, P&G is well-positioned to capitalize on the increasing demand for high-quality supplements and wellness products.
